Population pharmacokinetic model-predicted mean dinaciclib exposure ( area under the concentration-time curve extrapolated to infinity [ AUC [ I ] ] ) at 50 mg/m ( 2 ) was similar to that observed in a previous phase I trial , and no drug accumulation was observed after multiple-dose administration .